US-based healthcare company Baxter International is reportedly in advanced talks to acquire medical technology provider Hill-Rom Holdings for around $10bn.
Baxter is expected to pay up to $150 per Hill-Rom share to purchase its entire stock, people familiar with the matter told the Wall Street Journal.
The two companies are expected to reach a deal this week, said the report.
The latest talks follows an earlier bid of $144 per share by Baxter, which was rejected by Hill-Rom.
Established in 1915, Hill-Rom offers various products and services such as smart beds and surfaces, patient monitoring solutions, vision screening and diagnostic products and diagnostic cardiology solutions.
The company’s product portfolio also consist of safe patient handling and mobility solutions, care communication solutions, surgical workflow and precision monitoring solutions, physical exam and diagnostic solutions.
In addition, Hill-Rom provides healthcare furniture products, non-invasive respiratory therapy and procedural connectivity solutions.
In July this year, the company announced the launch of its Helion Integrated Surgical System in the US market, advancing its connected care solution for the operating room.
With the launch, the system is now available in approximately 20 countries worldwide.
The Helion System is designed to balance patient safety with operational efficiency and throughput, managing connections to operating room equipment and multiple hospital systems.
Employing 10,000 employees, Hill-Rom is engaged in enhancing outcomes for patients and caregivers by Advancing Connected Care.
In March 2019, the company agreed to acquire US-based mobile healthcare communications firm Voalte for $180m in cash.
Based in Sarasota of Florida, Voalte provides mobile communication platform, which enables care teams inside and outside the hospital to securely access and exchange information.
